History | Dupilumab for treating moderate to severe atopic dermatitis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 262 KB)

Published:

01 August 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 425 KB)

Published:

22 June 2018
Committee papers (PDF 2.38 MB)

Published:

22 June 2018
Public committee slides (PDF 557 KB)

Published:

22 June 2018

Draft guidance

Draft guidance
Public committee slides (PDF 907 KB)

Published:

03 April 2018
Appraisal consultation document (PDF 566 KB)

Published:

03 April 2018
Committee papers (PDF 9.17 MB)

Published:

03 April 2018

Invitation to participate

Final scope (PDF 83 KB)

Published:

03 October 2017
Final matrix (PDF 88 KB)

Published:

03 October 2017
NICE's response to comments on the draft scope and provisional matrix (MSWord 43 KB)

Published:

03 October 2017
Equality impact assessment (Scoping) (PDF 78 KB)

Published:

03 October 2017

Draft scope documents

Provisional matrix (pre-referral) (PDF 250 KB)

Published:

03 October 2017